Source comparison
Tesamorelin vs. Other GH Secretagogues: Cognitive Protocol Comparison
Before initiating a tesamorelin protocol, researchers often ask whether alternative GH secretagogues produce equivalent cognitive outcomes. The short answer: no. Mechanism matters. Tesamorelin GHRH receptor agonist Pulsatile, mimics endogenous rhythm Phase 2 t
This comparison does not assign a generated winner or score.
- Before initiating a tesamorelin protocol, researchers often ask whether alternative GH secretagogues produce equivalent cognitive outcomes. The short answer: no. Mechanism matters.
- Tesamorelin
- GHRH receptor agonist
- Pulsatile, mimics endogenous rhythm
- Phase 2 trials show 15–28% working memory improvement in 55+ subjects
- High. Best physiological alignment
- Ipamorelin
- Ghrelin receptor agonist
- Pulsatile but higher amplitude, shorter duration
- Limited cognitive data; primarily studied for body composition
- Moderate. Effective for GH elevation but less circadian synchronisation
- MK-677
- Ghrelin mimetic (oral)
- Sustained elevation, non-pulsatile
- Case reports suggest mood/sleep benefits; no controlled cognitive trials
- Low. Chronic GH elevation may downregulate receptors over time
- CJC-1295
- GHRH analogue with extended half-life
- Prolonged pulsatile secretion
- No published cognitive trials; mechanism similar to tesamorelin
- Moderate. Longer dosing intervals but less clinical validation
- Exogenous GH
- Direct GH replacement
- Non-physiological constant levels
- Mixed results; some studies show cognitive decline with supraphysiological dosing
- Low. Bypasses natural feedback loops
- Tesamorelin's advantage is specificity: it restores the pulsatile GH secretion pattern that cognitive function depends on without overriding the body's regulatory feedback. Explore high-purity research peptides designed for protocols requiring exact amino-acid sequencing and batch consistency.